News
and Media


Press Releases and Media
May 16, 2022 | Press Release
Revolo Biotherapeutics Announces Presentations at Upcoming Medical Meetings
Presenting new data on ‘1104 in allergic disease at the American Thoracic Society International Conference in San Francisco on May 17 Delivering an oral presentation on resetting the immune system to achieve long-term disease remission at the Treg Summit in Boston on May 19 NEW ORLEANS, LA and LONDON, UK, May 16, 2022 – Revolo …
Revolo Biotherapeutics Announces Presentations at Upcoming Medical Meetings Read More »
May 10, 2022 | Press Release
Revolo Biotherapeutics to Lead Panel Discussion on the Future of Autoimmune Disease Treatment
NEW ORLEANS, LA and LONDON, UK, May 10, 2022 – Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, today announced that its scientific team will be leading a virtual panel discussion on the future of …
May 5, 2022 | Press Release
Revolo Biotherapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
NEW ORLEANS, LA and LONDON, UK, May 05, 2022 – Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, today announced that its management team will participate in the LifeSci Partners Immunology & Inflammation Symposium being …